The attached article is the research study that has changed the standard treatment for Stage III adenocarcinoma NSCLC. The stats and discussion drain the brain a little, but most of the report is understandable for the lay person. Happy reading my detail interested friends.
Some vocab
adjuvant – applied after initial treatment for cancer, especially to suppress secondary tumour formation
unrsectable – inoperable
Epithelial Growth Factor Receptor (EGFR) mutation – An EGFR mutation is a change int he gene that codes for the epithelial growth factor receptor protein, which is involved in cell growth and survival. When the EGFR gene is mutated, it can cause cells to grow too much, which can lead to cancer. EGFR mutations are a common biomarker in non-small cell lung cancer (NSCLC). My cancer cells have the EGFR
